These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8019766)

  • 41. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
    Cotter MA; Ekberg K; Wahren J; Cameron NE
    Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ganglioside therapy in experimental diabetic neuropathy.
    Spüler M; Dimpfel W; Tüllner HU
    Arzneimittelforschung; 1988 Jul; 38(7):881-4. PubMed ID: 3207433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of adrenergic stimulation on sciatic nerve blood flow in diabetic and control rats.
    Vo PA; Tomlinson DR
    Eur J Pharmacol; 1997 Jun; 329(2-3):147-52. PubMed ID: 9226407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats.
    Jamali R; Mohseni S
    Acta Neuropathol; 2005 Feb; 109(2):198-206. PubMed ID: 15549329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amount and speed of fast axonal transport in diabetes.
    Abbate SL; Atkinson MB; Breuer AC
    Diabetes; 1991 Jan; 40(1):111-7. PubMed ID: 1707837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
    Kumar A; Kaundal RK; Iyer S; Sharma SS
    Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular Matrix Remodeling and Modulation of Inflammation and Oxidative Stress by Sulforaphane in Experimental Diabetic Peripheral Neuropathy.
    Moustafa PE; Abdelkader NF; El Awdan SA; El-Shabrawy OA; Zaki HF
    Inflammation; 2018 Aug; 41(4):1460-1476. PubMed ID: 29704151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
    Hounsom L; Horrobin DF; Tritschler H; Corder R; Tomlinson DR
    Diabetologia; 1998 Jul; 41(7):839-43. PubMed ID: 9686927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve.
    Zochodne DW; Ho LT
    Diabetologia; 1993 Jun; 36(6):493-6. PubMed ID: 8335170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats.
    Love A; Cotter MA; Cameron NE
    Eur J Clin Invest; 1996 Aug; 26(8):698-706. PubMed ID: 8872067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A disturbed macrocirculatory supply as a determinant for a reduced sciatic nerve blood flow in diabetic rats.
    Van Buren T; Kappelle AC; Kasbergen CM; Gispen WH; De Wildt DJ
    Eur J Pharmacol; 1996 Dec; 318(1):73-80. PubMed ID: 9007515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term suppression of postprandial hyperglycaemia with acarbose retards the development of neuropathies in the BB/W-rat.
    Sima AA; Chakrabarti S
    Diabetologia; 1992 Apr; 35(4):325-30. PubMed ID: 1516760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR; Gibson TM; Cotter MA; Cameron NE
    Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.
    Zhang W; Yorek M; Pierson CR; Murakawa Y; Breidenbach A; Sima AA
    Int J Exp Diabetes Res; 2001; 2(3):187-93. PubMed ID: 12369706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    Davidson EP; Holmes A; Coppey LJ; Yorek MA
    Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats.
    Hendriksen PH; Oey PL; Wieneke GH; van Huffelen AC; Gispen WH
    J Neurol Sci; 1992 Jul; 110(1-2):99-106. PubMed ID: 1506876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.
    Baum P; Koj S; Klöting N; Blüher M; Classen J; Paeschke S; Gericke M; Toyka KV; Nowicki M; Kosacka J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.
    Tuck RR; Schmelzer JD; Low PA
    Brain; 1984 Sep; 107 ( Pt 3)():935-50. PubMed ID: 6478183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats.
    Bíró K; Jednákovits A; Kukorelli T; Hegedüs E; Korányi L
    Brain Res Bull; 1997; 44(3):259-63. PubMed ID: 9323440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Salvemini D; Yorek MA
    Br J Pharmacol; 2001 Sep; 134(1):21-9. PubMed ID: 11522593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.